Prostate Cell News Volume 11.32 | Aug 28 2020

    0
    13







    PCN 11.32 | 28 Aug 2020


    Prostate Cell News by STEMCELL Technologies
    Vol. 11.32 – 28 August, 2020
    TOP STORY

    Epigenetic
    Silencing of the Ubiquitin Ligase Subunit FBXL7 Impairs C-SRC Degradation and Promotes Epithelial-to-Mesenchymal Transition and Metastasis

    Researchers showed that the promoter of the gene that encodes the ubiquitin ligase subunit FBXL7 was hypermethylated in advanced prostate and pancreatic cancers, correlating with decreased FBXL7 mRNA and protein levels.
    [Nature Cell Biology]

    Abstract

    Download an e-book covering the evolution of organoids, from their development to updated applications and future outlooks.
    PUBLICATIONSRanked by the impact factor of the journal

    Caveolin-1-Mediated
    Sphingolipid Oncometabolism Underlies a Metabolic Vulnerability of Prostate Cancer

    Mechanistic studies of the underlying tumor supportive onco-metabolism revealed coordinated activities through which caveolin-1 enabled rewiring of cancer cell lipid metabolism towards a program of exogenous sphingolipid scavenging independent of cholesterol, and increased cancer cell catabolism of sphingomyelins to ceramide derivatives.
    [Nature Communications]

    Full Article

    Targeted Radiosensitizers for MR-Guided Radiation Therapy of Prostate Cancer

    Scientists demonstrated prostate cancer-targeted gold nanoparticles for MR-guided radiotherapy to improve the targeting precision and efficacy.
    [Nano Letters]

    Abstract

    Anticancer
    Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells

    Investigators report on the potent anti-prostate cancer (PCa) activity of a small-molecule imidazoacridinone, C-1311. In androgen receptor (AR)-positive PCa cells, C-1311 was found to inhibit the transcriptional activity of AR, uncovering a novel mechanism that may be relevant for its anticancer effect.
    [Biomedicines]

    Full Article

    A Novel Method for Detection of Exfoliated Prostate Cancer Cells in Urine by RNA In
    Situ
    Hybridization

    Using cytology specimens prepared from spiked urine samples, researchers established the analytical validity of the RNA in situ hybridization assay for detection and visualization of prostate cells in urine.
    [Prostate Cancer and Prostatic Diseases]

    Abstract

    New
    Copper(i) Complexes Selective for Prostate Cancer Cells

    In general, all compounds showed higher cytotoxicity for the prostate cancer cells than for the breast cells, with IC50 values in the range 0.2-2 μM after 24 h of treatment.
    [Dalton Transactions]

    Abstract

    Physicochemical
    Damage and Early-Stage Biological Response to X-Ray Radiation Studied in Prostate Cancer Cells by Raman Spectroscopy

    Raman spectroscopy of prostate cancer cells fixed before and just after irradiation was undertaken to compare biochemical composition of irradiated cancer cells at both stages.
    [Journal of Biophotonics]

    Abstract

    Escherichia
    coli
    , a Common Constituent of Benign Prostate Hyperplasia-Associated Microbiota Induces Inflammation and DNA Damage in Prostate Epithelial Cells

    The effect of clinical isolates on nuclear factor‐κB activity and induction of DNA‐damage in the prostate epithelial cells were evaluated.
    [Prostate]

    Abstract

    Oleuropein:
    A Potential Inhibitor for Prostate Cancer Cell Motility by Blocking Voltage-Gated Sodium Channels

    Researchers report that oleuropein might be considered as a potential antimetastatic agent for prostate cancer due to its blocking effect on voltage-gated sodium channel-mediated cell motility.
    [Nutrition and Cancer-An International Journal]

    Abstract

    Molecular
    Evidence of IGFBP-3 Dependent and Independent VD3 Action and Its Nonlinear Response on IGFBP-3 Induction in Prostate Cancer Cells

    Changes in IGFBP-3 expression levels in LNCaP cells indicated that it mediated the inhibition of cell growth induced by VD3 treatment. IGFBP-3 was also found to be a mediator of the enhanced cytotoxicity of prostate cancer cells to VD3 in combination with the anti-cancer drug.
    [BMC Cancer]

    Full Article

    Five tips for returning to the lab after time off
    REVIEWS

    Angiogenesis Inhibition in Prostate Cancer: An Update

    Scientists summarize the different angiogenic growth factors that influence prostate cancer growth dynamics and review the outcomes of clinical trials conducted with antiangiogenic agents in prostate cancer patients.
    [Cancers]

    Full Article

    INDUSTRY AND POLICY NEWS

    RareCyte
    Announces First Commercially Available ARv7/Synaptophysin CTC Assay for Blood-Based Characterization of Treatment Resistant Prostate Cancer

    RareCyte® announced a new dual biomarker liquid biopsy assay for androgen receptor splice variant 7 (ARv7) and the neuroendocrine marker, synaptophysin (SYP), enabling customers to evaluate both ARv7 and SYP expression on circulating tumor cells with industry leading accuracy and precision in patients with prostate cancer.
    [RareCyte, Inc.]

    Press Release

    FEATURED EVENT

    Channels
    in Context: Structure and Function of Ion Channels in Macromolecular Complexes and Native Cells

    Sep 7 – 11, 2022
    Woods Hole, Massachusetts, United States


    > See All Events

    JOB OPPORTUNITIES


    Postdoctoral and Technician Position – Molecular Mechanism of Cancer

    Rutgers Cancer Institute of New Jersey – Rutgers, New Jersey, United States

    Postdoctoral
    Positions – Cancer Epigenomics

    West Virginia University – Morgantown, West Virginia, United States

    Postdoctoral Position – Immune Microenvironment, Stem Cell, and Cancer

    Brigham and Women’s Hospital, Harvard Medical School – Boston, Massachusetts, United States


    Postdoctoral Research Associate – Translational Cancer

    University of North Carolina at Chapel Hill – Chapel Hill, North Carolina, United States

    Postdoc – Cancer Biology and Cancer Microenvironments

    University of Copenhagen – Copenhagen, Denmark

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Prostate Cell News
    Archives Contact Us
    Prostate Cell News Twitter